Often, medicinal discovery has focused on minute compounds, but peptidic partners are increasingly receiving attention. This new strategy embraces combining peptidic sequences with complementary medicinal techniques to confront complex illness targets. By employing the specific features of peptidic compounds – such as high selectivity and deliver